A new data analysis technique has shown success in identifying the faulty genes that cause rare genetic diseases. A Struggle for Diagnosis Despite advances in sequencing technologies, rare disease patients still struggle to receive a diagnosis. Only 30% of patients receive a diagnosis after whole genome sequencing, which is often used as a last resort […]
Diagnostics allow for the identification of cancer types and other crucial biomarkers, and are used right through from discovery to market.
A new blood test has been shown to identify different cancer types with a high degree of accuracy. When cancer cells die, they shed their DNA into the blood. Previous diagnostic tests work by identifying the genetic mutations present in the cancer cell DNA. However, this technique is limited in its ability to distinguish where […]
We talked to Laxmi Parida, Fellow and Computational Genomics Research Lead at IBM, to discuss her recent ground-breaking research paper on an AI algorithm that can distinguish blood cancer subtypes from dark matter DNA. Personalised Medicine for Cancer Patients The future of personalised medicine relies on quick and non-invasive diagnostics. Simple blood tests for tumour […]
A newly developed ‘electronic nose’ can measure chemicals in the breath of small cancer lung patients to determine if they will respond to immunotherapy treatment. Immunotherapy is Changing Cancer Care Immunotherapy treatments harness the body’s immune system to fight the cancer cells, which is transforming the treatment of advanced stage cancers. However, only a small […]
The Digital DNA series explores the role of large-scale genetic testing in science, industry and society. We aim to understand both the benefits and risks of this emerging technology and see what the future may hold. In our third interview of the Digital DNA series we talked to Dr. Patrick Short, CEO of Sano Genetics. […]
Genomics Medicine Ireland (GMI) has announced the establishment of a Strategic Advisory Board that will work collaboratively with GMI in shaping the company’s strategy for the application of large-scale genomics population studies on the island of Ireland, in addition to providing input and advice on the multi-disciplinary integration of genomics into the Irish healthcare system. […]
A new technique to analyse the tumour DNA present in patient’s blood circulations is an effective method to monitor breast cancer progression. The technique has been shown to give a hundred-fold improvement in the detection limit for tumour DNA. Analysis of the DNA that the tumour sheds into the bloodstream provides a non-invasive means of […]
CUBATE ® PRESENTS DATA ON THE IC-MYCO ASSAY AT THE AMERICAN ASSOCIATION OF CLINICAL CHEMISTRY MEETING
THE IC-MYCO ASSAY WAS RECENTLY DESIGNATED “BREAKTHROUGH DEVICE” BY FDA Anaheim, Cal. August 8, 2019 – At the 71st Annual American Association of Clinical Chemistry Scientific Meeting and Clinical Lab Expo , iCubate ® , a provider of molecular diagnostic solutions for infectious disease detection, presented data on the company’s iC-Myco Assay. iCubate’s latest assay […]
Scientists have developed tattoos that change colour depending on the interstitial fluid concentration of key biomarkers. The development is a step towards developing quicker diagnostics. The biomarkers studied were pH, glucose and albumin. Variation of blood pH can be indictive of a range of health conditions and glucose sensing is extremely useful for monitoring diabetes. […]
Patients are not being informed about changes to their genetic risk factors for cancer, a new study shows. If an individual has a family history of a type of cancer, they can get a genetic test to identify their own cancer risk. Identifying a genetic risk means that person can get regular check-ups and be […]
uBiome, a Silicon Valley startup providing tests focussing on the microbiome and its importance to health, is under investigation after an FBI raid on its offices over how it was allegedly billing its customers. The company has received significant criticism recently for handling of the cofounders’ relationship and alleged corner-cutting during its scientific work.
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy,” epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
We spoke to Dr. David R. Hillyard MD, Chair and Medical Director of Molecular Infectious Diseases at ARUP Laboratories, about his work within the realm of infectious diseases and the increasing role of molecular diagnostics in combating pathogens.